Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Based on the current promising results with irinotecan and cetuximab in patients with
recurrent metastatic colorectal cancer, and the excellent results of Irinotecan and 5-FU in
gastric cancer , the present clinical study to evaluate the overall response rate, the time
to progression and the overall survival of the combined treatment of cetuximab and irinotecan
and 5-FU in patients with esophagogastric cancer is urgently needed.